Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome

Hsin Ching Lin, Michael Friedman, Hsueh Wen Chang, Mao Chang Su, Meghan N. Wilson

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 (p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0-10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p <0.0001, paired t test).

Original languageEnglish (US)
Pages (from-to)1070-1076
Number of pages7
JournalActa Oto-Laryngologica
Issue number9
StatePublished - Sep 2010

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology


Dive into the research topics of 'Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome'. Together they form a unique fingerprint.

Cite this